The U.S. Supreme Court signaled interest in deciding whether health insurers and pharmacy benefit managers face ERISA liability when negotiating drug prices on Monday, when it requested the government’s view in a case involving
The justices invited the U.S. solicitor general to file a brief giving the federal government’s views in a case asking whether negotiations over how much health plan participants pay for prescription drugs can give rise to fiduciary liability under the Employee Retirement Income Security Act.
The case challenges a 2009 deal in which Express Scripts, a PBM that coordinates prescription ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
